473 related articles for article (PubMed ID: 19059455)
1. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans.
Olsen GW; Chang SC; Noker PE; Gorman GS; Ehresman DJ; Lieder PH; Butenhoff JL
Toxicology; 2009 Feb; 256(1-2):65-74. PubMed ID: 19059455
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water.
Chang SC; Das K; Ehresman DJ; Ellefson ME; Gorman GS; Hart JA; Noker PE; Tan YM; Lieder PH; Lau C; Olsen GW; Butenhoff JL
Toxicol Sci; 2008 Jul; 104(1):40-53. PubMed ID: 18353799
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys.
Butenhoff JL; Kennedy GL; Hinderliter PM; Lieder PH; Jung R; Hansen KJ; Gorman GS; Noker PE; Thomford PJ
Toxicol Sci; 2004 Dec; 82(2):394-406. PubMed ID: 15470233
[TBL] [Abstract][Full Text] [Related]
4. A two-generation oral gavage reproduction study with potassium perfluorobutanesulfonate (K+PFBS) in Sprague Dawley rats.
Lieder PH; York RG; Hakes DC; Chang SC; Butenhoff JL
Toxicology; 2009 May; 259(1-2):33-45. PubMed ID: 19428941
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
6. Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC-MS/MS method.
Tominaga T; Negishi T; Hirooka H; Miyachi A; Inoue A; Hayasaka I; Yoshikawa Y
Toxicology; 2006 Sep; 226(2-3):208-17. PubMed ID: 16914249
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys.
Chang SC; Noker PE; Gorman GS; Gibson SJ; Hart JA; Ehresman DJ; Butenhoff JL
Reprod Toxicol; 2012 Jul; 33(4):428-440. PubMed ID: 21889587
[TBL] [Abstract][Full Text] [Related]
8. Toxicological evaluation of potassium perfluorobutanesulfonate in a 90-day oral gavage study with Sprague-Dawley rats.
Lieder PH; Chang SC; York RG; Butenhoff JL
Toxicology; 2009 Jan; 255(1-2):45-52. PubMed ID: 18992301
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the toxicokinetic behavior of perfluorohexanoic acid (PFHxA) and nonafluorobutane-1-sulfonic acid (PFBS) in cynomolgus monkeys and rats.
Chengelis CP; Kirkpatrick JB; Myers NR; Shinohara M; Stetson PL; Sved DW
Reprod Toxicol; 2009 Jun; 27(3-4):400-406. PubMed ID: 19429410
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of perfluorohexanesulfonate (PFHxS) in rats, mice, and monkeys.
Sundström M; Chang SC; Noker PE; Gorman GS; Hart JA; Ehresman DJ; Bergman Å; Butenhoff JL
Reprod Toxicol; 2012 Jul; 33(4):441-451. PubMed ID: 21856411
[TBL] [Abstract][Full Text] [Related]
11. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling.
Feng MR; Loo J; Wright J
Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of pramiverine in rats, dogs, and monkeys (author's transl)].
Steiner K; Diekmann HW; Garbe A; Nowak H
Arzneimittelforschung; 1976 Apr; 26(4b):717-21. PubMed ID: 821494
[TBL] [Abstract][Full Text] [Related]
13. Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO).
Hinderliter PM; Han X; Kennedy GL; Butenhoff JL
Toxicology; 2006 Aug; 225(2-3):195-203. PubMed ID: 16857306
[TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution, and milk secretion of the perfluoroalkyl acids PFBS, PFHxS, PFOS, and PFOA by dairy cows fed naturally contaminated feed.
Kowalczyk J; Ehlers S; Oberhausen A; Tischer M; Fürst P; Schafft H; Lahrssen-Wiederholt M
J Agric Food Chem; 2013 Mar; 61(12):2903-12. PubMed ID: 23441933
[TBL] [Abstract][Full Text] [Related]
15. Disposition and metabolism of [14C]brasofensine in rats, monkeys, and humans.
Zhu M; Whigan DB; Chang SY; Dockens RC
Drug Metab Dispos; 2008 Jan; 36(1):24-35. PubMed ID: 17908924
[TBL] [Abstract][Full Text] [Related]
16. In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differences.
Mehrotra N; Lal J; Puri SK; Madhusudanan KP; Gupta RC
Biopharm Drug Dispos; 2007 Jul; 28(5):209-27. PubMed ID: 17410524
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic effects of perfluorobutane sulfonate (PFBS) on the mallard and northern bobwhite quail.
Newsted JL; Beach SA; Gallagher SP; Giesy JP
Arch Environ Contam Toxicol; 2008 Apr; 54(3):535-45. PubMed ID: 17917760
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics of perfluorononanoic acid in rat and mouse.
Tatum-Gibbs K; Wambaugh JF; Das KP; Zehr RD; Strynar MJ; Lindstrom AB; Delinsky A; Lau C
Toxicology; 2011 Mar; 281(1-3):48-55. PubMed ID: 21237237
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
Nakamura A; Hirota T; Sugihara K; Morino A
Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
